Kraig Biocraft Laboratories Inc

Discover how Kraig Biocraft Laboratories uses recombinant DNA to create high‑strength, sustainable protein fibers—redefining the textile industry and boosting eco‑performance.

Discover how Kraig Biocraft Laboratories’ BAM‑1 Alpha platform won a high‑profile spider silk order from a top sports apparel brand, boosting its market impact.

Kraig Biocraft Laboratories is a pioneering company that is revolutionizing the materials industry through the development of high-strength, protein-based fibers using advanced recombinant DNA technology, while also prioritizing sustainability and e…

Kraig Biocraft Laboratories, Inc. is a pioneering company that is revolutionizing the materials industry through the development of high-strength, protein-based fibers using advanced recombinant DNA technology, with a focus on sustainability and inn…

Kraig Biocraft Laboratories Inc has set a new production record in spider silk technology, marking a significant advancement in the field with the successful implementation of automated reeling equipment.

Kraig Biocraft Laboratories is a pioneering company that is revolutionizing the materials industry with its sustainable, high-performance protein-based fibers developed using advanced recombinant DNA technology.

Kraig Biocraft Laboratories is revolutionizing the materials industry with sustainable, high-performance fibers made using recombinant DNA technology, aiming to redefine durability and sustainability standards.

Kraig Biocraft Laboratories is on the verge of finalizing a three-year collaboration with a Southeast Asian government agency to expand its recombinant spider silk manufacturing platform.

Kraig Biocraft Laboratories is revolutionizing the materials industry with its cutting-edge approach to sustainable innovation, using recombinant DNA technology to create high-performance, sustainable materials.

Kraig Biocraft Laboratories is pioneering sustainable materials in the textile industry through innovative, protein-based fibers developed using recombinant DNA technology.